Compare EDF & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EDF | OPRX |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Business Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.0M | 161.0M |
| IPO Year | 2010 | 2008 |
| Metric | EDF | OPRX |
|---|---|---|
| Price | $4.38 | $9.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $12.60 |
| AVG Volume (30 Days) | 161.4K | ★ 162.9K |
| Earning Date | 01-01-0001 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $4.35 | $4.54 |
| 52 Week High | $5.67 | $22.25 |
| Indicator | EDF | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 30.26 | 61.65 |
| Support Level | N/A | $5.85 |
| Resistance Level | $5.41 | $9.13 |
| Average True Range (ATR) | 0.14 | 0.46 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 3.35 | 65.44 |
Virtus Stone Harbor Emerging Markets Income Fund is a closed-end management investment company. Its investment objective is to maximize total return, which consists of income from its investments and capital appreciation. The Fund normally will invest at least 80% of its net assets (plus any borrowings for investment purposes) in emerging markets securities.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.